23 May 2019 Medications

Updated guide outlines risks of ‘natural’ interactions

23 May 2019 Biologics Clinical Psoriatic Athritis

Risk of nasty infections lower for psoriasis biologics

6 May 2019 Medications

Xeljanz rebate for PsA

16 April 2019 APLAR Biologics Medications

Game-changing RA drugs out of Third World’s reach

16 April 2019 Biologics Medications

Biosimilar launch will make affordable rituximab a reality

28 March 2019 Clinical Conditions DMARDS Medications Rheumatoid Arthritis

Take only as directed: high-dose Xeljanz poses PE risk

6 March 2019 Biologics Clinical Medications Psoriatic Athritis

New biologics for psoriatic arthritis

1 March 2019 Clinical Management Medications

What role for medical cannabis?

28 November 2018 MTX Psoriatic Athritis

What is the future of MTX for psoriatic arthritis?

Sponsored {{ ::category.name }}

Brought to you by {{ ::post.advertiser.name }}